Robert Helm, MD, FHRS received his BS in Biomedical Engineering at Johns Hopkins and his MD at Loyola University Chicago. He completed fellowships in cardiology and cardiac electrophysiology at Johns Hopkins. He is an Assistant Professor of Medicine and Radiology at Boston University and a clinical cardiac electrophysiologist at Boston Medical Center. He has expertise in atrial fibrillation (AF) and other arrhythmia disorders and has a very large clinical practice performing hundreds of ablation procedures annually. He has gained distinction within his field being recognized locally, regionally, and nationally for his clinical expertise in arrhythmia disorders including AF and cardiac resynchronization therapy. He is the Director of the Cardiac Device clinic, that follows approximately 5,000 patients. He oversees perioperative cardiac device management and MR imaging in patients with cardiac devices. As a Fellow of the Heart Rhythm Society he has served on the Scientific and Clinical Documents committee and as a member of the writing groups for the 2017 Expert Consensus Statement on Catheter and Surgical Ablation of AF and the expert consensus on Atrial Cardiomyopathies: Definition, Characterization, and Clinical Implication.
He is author of a number of peer-reviewed publications, invited reviews, and book chapters. In the past, he conducted translational research focused on pathobiology and assessment of mechanical dyssynchrony, which is associated with dilated cardiomyopathy and left bundle branch block. Much of his work focused on cardiac strain analysis using cardiac magnetic resonance imaging and how strain may be used to predict response to cardiac resynchronization therapy. This work was supported in part by National Heart, Lung, and Blood Institute grant P01 HL077180 and the training grant T32-HL07227. He served as the local PI for the Echocardiography Guided Cardiac Resynchronization Therapy (Echo-CRT) Trial, a clinical trial assessing effectiveness of using pacemakers for cardiac resynchronization therapy in patients with heart failure and narrow QRS (clinicaltrials.gov number, NCT00683696), and for the International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device (ADMIRE-ICD Trial), a clinical trial evaluating the efficacy of AndreViewtm imaging for identifying patients who are at low risk of sudden death to decision for implantable cardioverter-defibrillator (clinicaltrials.gov number, NCT02656329).
More recently, his research has focused on improving risk assessment and treatment of AF. He is currently conducting the Secondary Prevention of Atrial Fibrillation Randomized Pilot Study (ClinicalTrials.gov number, NCT03259893) funded by the Boston University Clinical and Translational Science Institute (CTSI). The trial is a hybrid implementation-effectiveness study testing the feasibility of a multidisciplinary AF program in combination with mobile health devices and comparing AF outcomes including burden and symptoms of AF, quality of life, and hospitalizations for AF. He is also the local PI for the Systematic Assessment of Geriatric Elements in Atrial Fibrillation (SAGE-AF, 1R01HL126911-01A1), which seeks to identify novel factors associated with clinical and patient-reported AC outcomes in a device cohort of older AF patients. He is also the local PI for Bariatric Restoration of Sinus (BAROS) Study (clinicaltrials.gov number, NCT04050969) and its sub-study, Biomarkers as Predictors of AF Outcomes after Bariatric Surgery and Catheter Ablation, which seeks to understand the mechanisms of AF by examining biomarkers and tissue as possible predictors of AF outcomes in patients undergoing AF ablation and to understand the role of inflammation and oxidative stress in AF. He is currently a collaborator on the Boston AHA AF SFRN Center.
- Assistant Professor, Radiology, Boston University School of Medicine
- Loyola University - Chicago Stritch School of Medicine, MD
- Johns Hopkins University, BS
- Published on 2/28/2020
L Percell R, Helm R, Monahan K. Incidence of Atrial Fibrillation in African Americans post Atrial Flutter Ablation. J Atr Fibrillation. 2020 Feb-Mar; 12(5):2254. PMID: 32435355.
- Published on 10/30/2019
McManus DD, Kiefe C, Lessard D, Waring ME, Parish D, Awad HH, Marino F, Helm R, Sogade F, Goldberg R, Hayward R, Gurwitz J, Wang W, Mailhot T, Barton B, Saczynski J. Geriatric Conditions and Prescription of Vitamin K Antagonists vs. Direct Oral Anticoagulants Among Older Patients With Atrial Fibrillation: SAGE-AF. Front Cardiovasc Med. 2019; 6:155. PMID: 31737647.
- Published on 10/1/2019
Saczynski JS, Sanghai SR, Kiefe CI, Lessard D, Marino F, Waring ME, Parish D, Helm R, Sogade F, Goldberg R, Gurwitz J, Wang W, Mailhot T, Bamgbade B, Barton B, McManus DD. Geriatric Elements and Oral Anticoagulant Prescribing in Older Atrial Fibrillation Patients: SAGE-AF. J Am Geriatr Soc. 2020 Jan; 68(1):147-154. PMID: 31574165.
- Published on 9/25/2019
Wang W, Saczynski J, Lessard D, Mailhot T, Barton B, Waring ME, Sogade F, Hayward R, Helm R, McManus DD. Physical, cognitive, and psychosocial conditions in relation to anticoagulation satisfaction among elderly adults with atrial fibrillation: The SAGE-AF study. J Cardiovasc Electrophysiol. 2019 11; 30(11):2508-2515. PMID: 31515920.
- Published on 4/22/2019
Karnik AA, Helm RH, Gaskill MD, Dermovsesian A, Monahan KM. High impedance alert with safety switching: An unreported hazard of hybrid pacing systems. J Cardiovasc Electrophysiol. 2019 07; 30(7):1102-1107. PMID: 30983092.
- Published on 4/2/2019
Long MT, Ko D, Arnold LM, Trinquart L, Sherer JA, Keppel SS, Benjamin EJ, Helm RH. Gastrointestinal and liver diseases and atrial fibrillation: a review of the literature. Therap Adv Gastroenterol. 2019; 12:1756284819832237. PMID: 30984290.
- Published on 2/22/2019
Karnik AA, Gopal DM, Ko D, Benjamin EJ, Helm RH. Epidemiology of Atrial Fibrillation and Heart Failure: A Growing and Important Problem. Cardiol Clin. 2019 May; 37(2):119-129. PMID: 30926013.
- Published on 2/1/2019
Helm RH, Varkey SC, Karnik AA. Differential effective refractory period as a useful marker of multiple accessory pathways. J Arrhythm. 2019 Apr; 35(2):296-299. PMID: 31007797.
- Published on 1/6/2019
Karnik AA, Helm RH, Monahan KM. Mechanisms and management of inappropriate therapy in subcutaneous implantable cardioverter defibrillators. J Cardiovasc Electrophysiol. 2019 03; 30(3):402-409. PMID: 30576031.
- Published on 1/1/2018
Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, Akar JG, Badhwar V, Brugada J, Camm J, Chen PS, Chen SA, Chung MK, Cosedis Nielsen J, Curtis AB, Davies DW, Day JD, d'Avila A, Natasja de Groot NMS, Di Biase L, Duytschaever M, Edgerton JR, Ellenbogen KA, Ellinor PT, Ernst S, Fenelon G, Gerstenfeld EP, Haines DE, Haissaguerre M, Helm RH, Hylek E, Jackman WM, Jalife J, Kalman JM, Kautzner J, Kottkamp H, Kuck KH, Kumagai K, Lee R, Lewalter T, Lindsay BD, Macle L, Mansour M, Marchlinski FE, Michaud GF, Nakagawa H, Natale A, Nattel S, Okumura K, Packer D, Pokushalov E, Reynolds MR, Sanders P, Scanavacca M, Schilling R, Tondo C, Tsao HM, Verma A, Wilber DJ, Yamane T. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Europace. 2018 01 01; 20(1):e1-e160. PMID: 29016840.
View 29 more publications: View full profile at BUMC